Monospecific high-affinity and complement activating anti-GM1 antibodies are determinants in experimental axonal neuropathy.

Source:http://linkedlifedata.com/resource/pubmed/id/20382399

J. Neurol. Sci. 2010 Jun 15 293 1-2 76-81

Download in:

View as

General Info

PMID
20382399